Search by Drug Name or NDC

    NDC 00003-2188-21 ORENCIA 125 mg/mL Details

    ORENCIA 125 mg/mL

    ORENCIA is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by E.R. Squibb & Sons, L.L.C.. The primary component is ABATACEPT.

    Product Information

    NDC 00003-2188
    Product ID 0003-2188_ca83b90c-3ec0-4803-bf69-18c035bc41f0
    Associated GPIs 6640001000E520 6640001000D520
    GCN Sequence Number 067681
    GCN Sequence Number Description abatacept SYRINGE 125 MG/ML SUBCUT
    HIC3 S2Q
    HIC3 Description ANTINFLAMMATORY, SEL.COSTIM.MOD.,T-CELL INHIBITOR
    GCN 30289
    HICL Sequence Number 037825
    HICL Sequence Number Description ABATACEPT
    Brand/Generic Brand
    Proprietary Name ORENCIA
    Proprietary Name Suffix n/a
    Non-Proprietary Name abatacept
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 125
    Active Ingredient Units mg/mL
    Substance Name ABATACEPT
    Labeler Name E.R. Squibb & Sons, L.L.C.
    Pharmaceutical Class Decreased Cytokine Activity [PE], Recombinant Fusion Proteins [CS], Selective T Cell Costimulation Modulator [EPC]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125118
    Listing Certified Through 2024-12-31

    Package

    NDC 00003-2188-21 (00003218821)

    NDC Package Code 0003-2188-21
    Billing NDC 00003218821
    Package 1 SYRINGE, GLASS in 1 CARTON (0003-2188-21) / 1 mL in 1 SYRINGE, GLASS
    Marketing Start Date 2013-10-01
    NDC Exclude Flag N
    Pricing Information N/A